Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Asset Utilization Ratio (2024 - 2026)

Surrozen (SRZN) posted quarterly Asset Utilization Ratio of 0.07 for Q1 2026, down 52.08% year-over-year from 0.14 in Q1 2025, and up 89.34% quarter-over-quarter from 0.04 in Q4 2025.

Analysis

Surrozen (SRZN) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Surrozen's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.07 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 52.08% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (down 52.08% YoY), while the FY2025 annual figure was 0.05, down 79.04% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.07, up from 0.04 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.22 in Q4 2024, with the low at 0.04 in Q4 2025.
  • The 3-year median for Asset Utilization Ratio is 0.12 (2025), against an average of 0.12.
  • The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio sank 83.67% in 2025, then tumbled 52.08% in 2026.
  • Surrozen's Asset Utilization Ratio stood at 0.22 in 2024, then tumbled by 83.67% to 0.04 in 2025, then soared by 89.34% to 0.07 in 2026.
  • Business Quant data shows SRZN's Asset Utilization Ratio at 0.07 in Q1 2026, 0.04 in Q4 2025, and 0.04 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Surrozen 263.35 Mn 263.35 Mn - 0.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.10
Mar 31, 2026 0.07
Dec 31, 2025 0.04
Sep 30, 2025 0.04
Jun 30, 2025 0.12
Mar 31, 2025 0.14
Dec 31, 2024 0.22
Sep 30, 2024 0.21